Reading between the (guide)lines - The KDIGO practice guideline on acute kidney injury in the individual patient

Kidney International

Volumn 85, Issue 1, 2014, Pages 39-48

  Okusa, Mark D ^a   Davenport, Andrew ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

acute kidney injury; creatinine; KDIGO; RIFLE

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; AMPHOTERICIN B; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; NATRIURETIC FACTOR; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CLINICAL FEATURE; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ACUTE KIDNEY INJURY; HUMANS; PATIENT CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 84891559103     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.378     Document Type: Review

References (64)

1. Clinical Practice Guidelines. Directions for a New Program. Institute of Medicine: Washington, DC, USA, 1990.
2. Woolf SH, Grol R, Hutchinson A et al. Clinical guidelines - potential benefits, limitations, and harms of clinical guidelines. Brit Med J. 1999; 318: 527-530. (Pubitemid 29189000)
3. Berger JT, Rosner F. The ethics of practice guidelines. Arch Intern Med 1996; 156: 2051-2056. (Pubitemid 26346962)
4. Grimshaw JM, Russell IT. Effect of clinical guidelines on medicalpractice - a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322. (Pubitemid 23345178)
5. Bellomo R, Ronco C, Kellum JA et al. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
6. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
7. Joannidis M, Metnitz B, Bauer P et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009; 35: 1692-1702.
8. Macedo E, Bouchard J, Soroko SH et al. Program to Improve Care in Acute Renal Disease Study. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 2010; 14: R82.
9. Zavada J, Hoste E, Cartin-Ceba R. AKI6 investigators. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant 2010; 25: 3911-3918.
10. Hoste EA, Cruz DN, Davenport A et al. The epidemiology of cardiac surgery-Associated acute kidney injury. Int J Artif Organs 2008; 31: 158-165. (Pubitemid 351425013)
11. Davenport A, Cholongitas E, Xirouchakis E et al. Pitfalls in assessing renal function in patients with cirrhosis - potential inequity for access to treatment of hepatorenal failure and liver transplantation. Nephrol Dial Transplant 2011; 26: 2735-2742.
12. Nejat M, Pickering JW, Devarajan P et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012; 81: 1254-1262.
13. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494. (Pubitemid 26140761)
14. Coca SG, Yusuf B, Shlipak MG et al. Long-Term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-Analysis. Am J Kidney Dis 2009; 53: 961-973.
15. Parikh NI, Hwang SJ, Larson MG et al. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006; 166: 1884-1891. (Pubitemid 44455172)
16. Hsu CY. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 2007; 16: 221-226.
17. Hsu CY, Chertow GM, McCulloch CE et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009; 4: 891-898.
18. Goldstein SL, Jaber BL, Faubel S et al. Acute Kidney Injury Advisory Group of the American Society of Nephrology. AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol 2013; 8: 476-483.
19. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012; 6: CD000567.
20. Finfer S, Bellomo R, Boyce N et al. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256. (Pubitemid 38669207)
21. Perner A, Haase N, Guttormsen AB et al. 6S Trial GroupScandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134.
22. Shaw AD, Bagshaw SM, Goldstein SL et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255: 821-829.
23. Yunos NM, Bellomo R, Bailey M. Chloride-restrictive fluid administration and incidence of acute kidney injury - reply. JAMA 2013; 309: 543-544.
24. Chowdhury AH, Cox EF, Francis ST et al. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lytes 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256: 18-24.
25. Landry DW, Levin HR, Gallant EM et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122-1125. (Pubitemid 27097820)
26. Russell JA, Walley KR, Singer J et al. VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877-887. (Pubitemid 351397087)
27. Rivers E, Nguyen B, Havstad S et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
28. Lin SM, Huang CD, Lin HC et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006; 26: 551-557.
29. Brienza N, Giglio MT, Marucci M et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-Analytic study. Crit Care Med 2009; 37: 2079-2090.
30. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
31. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461. (Pubitemid 43200296)
32. NICE-SUGAR Study InvestigatorsFinfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
33. Heyman SN, Rosen S, Epstein FH et al. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int 1994; 45: 981-985. (Pubitemid 24234713)
34. Heyman SN, Brezis M, Greenfeld Z et al. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989; 14: 377-385. (Pubitemid 20017575)
35. Mehta RL, Pascual MT, Soroko S et al. PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288: 2547-2553. (Pubitemid 35386889)
36. Grams ME, Estrella MM, Coresh J et al. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966-973.
37. Barclay ML, Kirkpatrick CM, Begg EJ. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet 1999; 36: 89-98. (Pubitemid 29121683)
38. Ali MZ, Goetz MB. A meta-Analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809. (Pubitemid 27193857)
39. Ramsey BW, Pepe MS, Quan JM et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999; 340: 23-30. (Pubitemid 29024680)
40. Cannella CA, Wilkinson ST. Acute renal failure associated with inhaled tobramycin. Am J Health Syst Pharm 2006; 63: 1858-1861. (Pubitemid 44477457)
41. Izquierdo MJ, Gomez-Alamillo C, Ortiz F et al. Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa. Clin Nephrol 2006; 66: 464-467. (Pubitemid 44896157)
42. Mller CH, Penninga L, Wetterslev J et al. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database Syst Rev 2012; 3: CD007224.
43. Seabra VF, Alobaidi S, Balk EM et al. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-Analysis of randomized controlled trials. Clin J Am Soc Nephrol 2010; 5: 1734-1744.
44. Garg AX, Devereaux PJ, Yusuf S et al. CORONARY Investigators. Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial. BMJ Open 2012; 2: e001080.
45. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399. (Pubitemid 39303939)
46. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386. (Pubitemid 43145062)
47. Li XM, Cong HL, Li TT et al. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention. Chin Med J (Engl) 2011; 124: 2101-2106.
48. Shemirani H, Pourrmoghaddas M. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. Saudi J Kidney Dis Transpl 2012; 23: 280-285.
49. Kushner FG, Hand M, Smith SC Jr et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am CollCardiol 2009; 54: 2205.
50. Owen RJ, Hiremath S, Myers A et al. Consensus Guidelines for the Prevention of Contrast Induced Nephropathy. Canadian Association of Radiologists. http://www.car.ca/uploads/standards%20guidelines/ 20110617-en-prevention-cin.pdf. Accessed 1 July 2012.
51. Segal A, Ellis JH, Baumgartner BR et al. Manual on Contrast Media: Version 6; 2008. ACR Am CollRadiol. http://www.acr.org/Quality-Safety/ Resources/Contrast-Manual. Accessed 1 July 2012.
52. Heinrich MC, Ha?berle L, Mu? ller V et al. Nephrotoxicity of iso-osmolariodixanol compared with nonionic low-osmolar contrast media: meta-Analysis of randomized controlled trials. Radiology 2009; 250: 68-86.
53. Haneder S, Augustin J, Jost G et al. Impact of iso- and low-osmolar iodinated contrast agents on BOLD and diffusion MRI in swine kidneys. Invest Radiol 2012; 47: 299-305.
54. Bolognese L, Falsini G, Schwenke C et al. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Am J Cardiol 2012; 109: 67-74.
55. Shin DH, Choi DJ, Youn TJ et al. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography. Am J Cardiol 2011; 108: 189-194.
56. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast mediaassociated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336. (Pubitemid 34127411)
57. Zoungas S, Ninomiya T, Huxley R et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151: 631-638.
58. Stevens MA, McCullough PA, Tobin KJ et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411. (Pubitemid 29234202)
59. Cho R, Javed N, Traub D et al. Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. J Interv Cardiol 2010; 23: 460-466.
60. Wró bel W, Sinkiewicz W, Gordon M et al. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol 2010; 68: 1015-1020.
61. Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982; 7: 93-107. (Pubitemid 12070476)
62. Pendyala L, Creaven PJ. Pharmacokinetic and pharmacodynamic studies of N-Acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol Biomarkers Prev 1995; 4: 245-251.
63. Fishbane S. N-Acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 2008; 3: 281-287.
64. Shemirani H, Pourrmoghaddas M. A. Randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. Saudi J Kidney Dis Transpl 2012; 23: 280-285.